Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines

Reporting results of cancer treatment

1981 • 7,916 citations

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1992 • 619 citations

Preclinical evaluation of docetaxel (Taxotere).

1995 • 215 citations

Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

1997 • 156 citations

Vinorelbine (Navelbiner`): A Third-Generation Vinca Alkaloid

1997 • 83 citations

Paclitaxel

1998 • 82 citations

Vinorelbine Tartrate and Paclitaxel Combinations: Enhanced Activity Against In Vivo P388 Murine Leukemia Cells

1995 • 72 citations

Current options in treatment of anthracycline-resistant breast cancer

1999 • 65 citations

Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor

2001 • 44 citations

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study

2000 • 34 citations

Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancer patients with prior anthracycline exposure

2000 • 34 citations

Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel

1998 • 32 citations

Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer.

1997 • 27 citations

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

2001 • 24 citations

Docetaxel in combination with doxorubicin or vinorelbine

1997 • 21 citations

Diffuse large-cell lymphoma

2000 • 19 citations